Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMIVER: Remifentanil vs nitrous oxide for analgesia during external cephalic version
2011-003952-37Phase 4Active
- Sponsor
- LUIS FERN�NDEZ- LLEBREZ DEL REY
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remifentanil in breech presentation and Pain associated with external cephalic version (2 arms), sponsored by LUIS FERN�NDEZ- LLEBREZ DEL REY. Primary endpoint: Success rate of external cephalic version. Started Feb 2012; status: active.
02
Drugs
remifentanil
03
Conditions
breech presentationPain associated with external cephalic version
Beyond the preview
Go deeper on 2011-003952-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003952-37.